Vaccine innovations for emerging infectious diseases-a symposium report.

Abstract

Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled "Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats," held on May 20, 2019.

• Authors: Jennifer Cable, Padmini Srikantiah, James E Crowe Jr, Bali Pulendran, Adrian Hill, Ann Ginsberg, Wayne Koff, Anuja Mathew, Tony Ng, Kathrin Jansen, Gregory Glenn, Sallie Permar, Ian Wilson, David B Weiner, Drew Weissman, Rino Rappuoli
• Journal: Annals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1462 Issue 1 Pg. 14-26 (02 2020) ISSN: 1749-6632 [Electronic] United States
• PMID: 31659752 (Publication Type: Journal Article, Review)
• Copyright: © 2019 New York Academy of Sciences.

Chemical References

• Vaccines

Topics

• Animals
• Clinical Trials as Topic (methods)
• Communicable Disease Control
• Communicable Diseases (drug therapy, epidemiology)
• Communicable Diseases, Emerging (epidemiology, prevention & control)
• Congresses as Topic (trends)
• Humans
• New York City
• Research Report (trends)
• Therapies, Investigational (methods, trends)
• Vaccines (administration & dosage)